Publication Date
| In 2026 | 0 |
| Since 2025 | 0 |
| Since 2022 (last 5 years) | 0 |
| Since 2017 (last 10 years) | 0 |
| Since 2007 (last 20 years) | 1 |
Descriptor
| Autism | 1 |
| Behavior Problems | 1 |
| Check Lists | 1 |
| Comparative Analysis | 1 |
| Drug Use | 1 |
| Effect Size | 1 |
| Pervasive Developmental… | 1 |
| Pharmacology | 1 |
| Social Behavior | 1 |
| Social Desirability | 1 |
| Withdrawal (Psychology) | 1 |
| More ▼ | |
Source
| Journal of Autism and… | 1 |
Author
| Aman, Michael G. | 1 |
| Arnold, L. Eugene | 1 |
| Deng, Yanhong | 1 |
| Dziura, James | 1 |
| Hallett, Victoria | 1 |
| McCracken, James T. | 1 |
| McDougle, Christopher J. | 1 |
| Scahill, Lawrence | 1 |
| Tierney, Elaine | 1 |
| Vitiello, Benedetto | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Aberrant Behavior Checklist | 1 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkScahill, Lawrence; Hallett, Victoria; Aman, Michael G.; McDougle, Christopher J.; Arnold, L. Eugene; McCracken, James T.; Tierney, Elaine; Deng, Yanhong; Dziura, James; Vitiello, Benedetto – Journal of Autism and Developmental Disorders, 2013
There is growing interest in measuring social disability as a core element of autism spectrum disorders in medication trials. We conducted a secondary analysis on the Aberrant Behavior Checklist Social Withdrawal subscale using data from two federally-funded, multi-site, randomized trials with risperidone. Study 1 included 52 subjects assigned to…
Descriptors: Autism, Pharmacology, Effect Size, Pervasive Developmental Disorders
